DISPARITIES IN CANCER CARE: AN URGENT GLOBAL NEED
With nearly 20 million cancer cases in 2022 (19.95 as reported by Globocan) and 27 million new cancer cases expected by 2040, the need to improve access to radiation therapy has never been more critical.
learn moreA UNIQUE COLLABORATION, A SINGLE GOAL
Radiation oncologists, physicists, biomedical researchers, healthcare executives, and advanced computing experts from various backgrounds have a common goal: to increase access to high-quality cancer treatment and care for underserved populations globally.
learn more
BETTER RADIATION TREATMENT, AT LOWER COST
STELLA is addressing the global shortage of linear accelerators by offering a new, technologically disruptive, more affordable and easier to maintain LINAC-based radiation therapy system.
learn moreDISRUPTIVE TECHNOLOGY DRIVING A SOLUTION
The STELLA team includes collective world-class experts in accelerator and medical physics, engineering design, artificial intelligence (AI) and machine learning (ML), cloud technology, and drawing on significant user input from healthcare professionals in LMICs and HICs.
learn more
EXPANDING LIFESAVING CANCER CARE: A FUNDING OPPORTUNITY
The ICEC and its partners are seeking immediate financial support to develop the LINAC prototype, the associated software systems and the training and mentoring programs.
learn more